Mirae Asset Global Etfs Holdings Ltd. Galectin Therapeutics Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Galectin Therapeutics Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 374 shares of GALT stock, worth $1,589. This represents 0.0% of its overall portfolio holdings.
Number of Shares
374
Previous 4,388
91.48%
Holding current value
$1,589
Previous $5,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding GALT
# of Institutions
95Shares Held
11.2MCall Options Held
134KPut Options Held
353K-
Vanguard Group Inc Valley Forge, PA2.18MShares$9.28 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.56MShares$6.65 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ1.27MShares$5.38 Million0.01% of portfolio
-
Jane Street Group, LLC New York, NY749KShares$3.18 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA666KShares$2.83 Million0.0% of portfolio
About GALECTIN THERAPEUTICS INC
- Ticker GALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,426,000
- Market Cap $253M
- Description
- Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...